P

PainReform Ltd
D

PRFX

0.51010
USD
-0.02
(-3.75%)
Market Open
Volume
100
EPS
0
Div Yield
0
P/E
-0
Market Cap
1,135,713
News

Title: PainReform Ltd

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.